Figures
Abstract
Background
Low birth weight and slow growth during infancy are associated with increased rates of chronic diseases in adulthood. Associations with risk factors such as fasting glucose and lipids concentrations are weaker than expected based on associations with disease. This could be explained by differences in postprandial responses, which, however, have been little studied. Our aim was to examine the impact of growth during infancy on postprandial responses to a fast-food meal (FF-meal) and a meal, which followed the macro-nutrient composition of the dietary guidelines (REC-meal).
Methodology/Principal Findings
We recruited 24 overweight 65–75 year-old subjects, 12 with slow growth during infancy (SGI-group) and 12 with normal early growth. All the subjects were born at term. The study meals were isocaloric and both meals were consumed once. Plasma glucose, insulin, triglycerides (TG) and free fatty acids (FFA) were measured in fasting state and over a 4-h period after both meals. Subjects who grew slowly during infancy were also smaller at birth. Fasting glucose, insulin or lipid concentrations did not differ significantly between the groups. The TG responses were higher for the SGI-group both during the FF-meal (P = 0.047) and the REC-meal (P = 0.058). The insulin responses were significantly higher for the SGI-group after the FF-meal (P = 0.036). Glucose and FFA responses did not differ significantly between the groups.
Citation: Perälä M-M, Valsta LM, Kajantie E, Leiviskä J, Eriksson JG (2011) Impact of Early Growth on Postprandial Responses in Later Life. PLoS ONE 6(8): e24070. https://doi.org/10.1371/journal.pone.0024070
Editor: Stefan Kiechl, Innsbruck Medical University, Austria
Received: March 29, 2011; Accepted: July 29, 2011; Published: August 31, 2011
Copyright: © 2011 Perälä et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the Academy of Finland, British Heart Foundation, Emil Aaltonen Foundation, Finnish Foundation for Pediatric Research, Finska Läkaresällskapet, Samfundet Folkhälsan, Juho Vainio Foundation, Novo Nordisk Foundation, Päivikki and Sakari Sohlberg Foundation, Signe and Ane Gyllenberg Foundation, Sigrid Juselius Foundation, Yrjö Jahnsson Foundation, the Diabetes Research Foundation, Finnish Foundation for Cardiovascular Research, and the Finnish Graduate School on Applied Bioscience. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Epidemiological studies have shown that low birth weight is associated with an increased risk of several chronic diseases in later life, as reviewed by Huxley et al [1] and Whincup et al [2]. The Developmental Origins of Health and Disease (DOHaD) hypothesis suggests that a sub-optimal environment in utero alters growth and metabolism to ensure survival [3]. These adaptations result in long term alterations in the structure and function of various organs and may result in adverse health outcomes in adult life [4]. There is also evidence that sensitive early life periods are not limited to fetal life, for example specific growth patterns reflecting conditions during infancy may increase the probability of unfavorable metabolic outcomes and diseases [5]–[10].
Several studies have reported an association between small size at birth and slow growth during infancy and fasting hyperglycemia, insulin resistance [10] and unfavorable lipid profiles [11]–[14]. Associations between birth size and risk factors of cardiovascular diseases (CVD) such as fasting lipids concentrations [11]–[14] are weaker than expected based on associations between birth size and CVD [1], [5]. Only few studies have examined the effect of birth weight on postprandial responses to mixed meals [15]–[17]. To our knowledge, no previous studies have assessed the effect of growth during infancy on postprandial responses. However, people are spending most of their waking hours in a postprandial state, and it has been shown that elevated postprandial responses are stronger predictors of CVD than fasting levels [18]–[20]. Elevated postprandial responses of glucose and lipids may cause accumulation of atherogenic particles and generate excess free radicals that may have effect on inflammation and endothelial dysfunction [21], [22]. These postprandial changes can lead to the development of CVD when repeating many times daily.Therefore, alterations in postprandial responses could potentially explain in part the associations of early growth with adult diseases that are not explained by conventional risk factors such as fasting concentrations of glucose, insulin and lipids.
The aim of the present study was to examine the impact of growth during infancy on triglycerides (TG), free fatty acids (FFA), glucose, and insulin postprandial responses to a fast-food meal (FF-meal) and a meal, which followed the macronutrient composition of the dietary guidelines (REC-meal).
Methods
Ethics statement
This study was conducted according to the guidelines laid down in the Declaration of Helsinki, and all procedures involving human subjects were approved by the Ethics Committee of Hospital District of Helsinki and Uusimaa. Written informed consent was obtained from all the subjects.
Participants
We recruited 24 overweight or obese (body mass index, BMI, 25–32 kg/m2) 65–75 year-old subjects, 12 with slow growth during infancy (SGI-group) and 12 with normal early growth (CON-group) from the Helsinki Birth Cohort Study participants who had attended a clinical study [13] and who were born at term. Data on childhood growth were based on repeated measurements at child welfare clinics which have been described in detail [9]. Growth during infancy was examined as gains in BMI between birth and 1 year. We converted each measurement of BMI for each individual to a Z-score, which represents the difference from the mean value for the whole study group (n = 2003) and is expressed in standard deviations. We examined how much BMI at 1 year of age differed from that predicted by the BMI at birth by using the residual from linear regression; we called this measure “conditional growth”. Subjects with slow early growth had conditional growth <−0.9 SD, and the conditional growth of the control group was >−0.9 SD. The conditional growth cut-off point was based on the previous study of our cohort [13] which showed that a 1 SD higher conditional BMI at 24 months was associated with 3.9% lower serum TG concentration.
Glucose tolerance was assessed by a 75 g 2-h oral glucose tolerance test (OGTT), and diabetics were excluded. Other exclusion criteria were smoking, milk allergy, regular medication that would have an effect on postprandial glucose or lipids metabolism (e.g. antidiabetic drugs, fibrates, glucocorticoids), gastrointestinal disease influencing absorption, or a first-degree family history of diabetes. In addition, we excluded those who were born pre-term (before 37 weeks of gestation). Diet, health and lifestyle data were assessed by questionnaires. The subjects' mean energy intake was calculated on the basis of their basal metabolic rate, taking into account the questionnaire data on daily physical activity at work and leisure time [23].
Study Design
The study followed a crossover design. Subjects were recruited to participate in a random order on two 1-day studies, separated by approximately one week. The subjects were advised to follow their usual diet during the study period. In addition, they were not allowed to drink alcohol, and were asked to avoid strenuous exercise and sauna for 24 hours before each study day. Moreover, the subjects were advised not to take lipid lowering medication (statins) preceding the study day. The day before the study visit, they were asked to eat an evening meal, in accordance with instructions they had been given, that would provide 15% of the calculated daily energy requirement. The carbohydrate content of the evening meals was 55% energy. The subjects were also asked to fast for 10 to 12 hours after their standardized evening meal, to avoid exercise in the morning of the study, and to arrive at the clinic by car or public transportation.
In the study clinic, height was measured to the nearest 0.1 cm and weight to the nearest 0.1 kg. BMI was calculated as weight (in kg) divided by the square of height (in m). Waist circumference was measured in standing position, with the legs slightly apart, in the midway between the lowest ribs and the iliac crest. Changes of up to two kilos (kg) in weight were allowed during the study. An intravenous cannula was inserted into an antecubital vein in the forearm and an intravenous blood sample (8 ml) was drawn. Thereafter the subjects consumed the test meal within 10 minutes. After the start of the meal intravenous blood samples were collected at 15, 30, 60, 90, 120, 180 and 240 minutes.
Each subject tested two different study meals, a fast-food meal (FF-meal) and a meal, which followed the macronutrient composition of the dietary guidelines [24] and included 52% energy as carbohydrate, 14% energy as protein and 34% energy as fat (REC-meal) on a separate day. The commercial FF-meal consisted of a BigMac hamburger, french fries and light cola. Both test meals contained the same amount of energy (∼3400 kJ = ∼800 kcal). The foodstuffs and the nutrient composition of the study meals are shown in Table 1.
Laboratory analysis
Blood glucose was analyzed by a glucose meter (HemoCue Glucose 201+ meter, LtD, Espoo, Finland) which expresses concentrations as mmol/L of plasma glucose. The HemoCue Glucose system is based on a glucose dehydrogenase method [25]. A quality-control solution recommended by HemoCue was measured twice every study morning; the coefficient of variation (CV) of these measurements was 0.8%. Blood for determination of plasma TG, FFA and insulin were collected in EDTA K2 tubes (Venosafe TM, Terumo Sweden AB, Västra Frölunda, Sweden). Samples were centrifuged for 15 min at 4000 rpm (Rotofix 32, Hettich Zentrifugen, Tuttlingen, Germany) immediately after the sample collecting and the separated plasma was stored at −70°C until analyzed. Plasma concentrations of TG were measured by enzymatic GPO method (Abbott Laboratories, Abbott Park, IL, USA) [26], FFA were measured by enzymatic colorimetric method (NEFA-HR(2),Wako Chemicals GmbH, Neuss, Germany) [27], and insulin was determined by Chemiluminescent Microparticle Immunoassay (CMIA) [28] with Abbott reagents. Fasting total cholesterol at baseline was analyzed by using an enzymatic method (Abbott Laboratories, Abbott Park, IL, USA). All laboratory analyses were carried out at the National Institute for Health and Welfare, Helsinki, Finland using Architect ci8200 analyzer (Abbott Laboratories, Abbott Park, IL, USA).
The inter-assay CV of TG at the levels of 1.35 mmol/L and 4.93 mmol/L were 1.7% and 1.3%, and intra-assay CV was 0.6%. The inter-assay CV of FFA at the levels of 0.59 mmol/L and 1.11 mmol/L were 1.8% and 1.7%, and intra-assay CV varied from 0.3% (low level control) to 0.8 (high level control). The CVs of insulin at the levels of 187 pmol/L and 1191 pmol/L were 1.6% and 2.5%, and intra-assay CV was 1.7%.
Statistical methods
The 4-h incremental area under the TG, glucose and insulin response curve (IAUC) and the 4-h incremental area over the FFA response curve (IAOC), were calculated using a trapezoidal method [29] for both test meal. In addition, the 2-h glucose and insulin IAUC were also calculated. One subject's insulin IAUC results were excluded from the FF-meal analysis because the fasting insulin value was high and differed markedly from the fasting value of the previous study day and fasting values of other subjects.
The variables with abnormal distribution (glucose and insulin responses) were normalized with logarithmic transformation. An independent sample t-test was used for testing the differences in subjects' baseline characteristics and postprandial responses between study groups. All statistical analyses were done using the PASW Statistics version 18 for Windows® (SPSS Inc., Chicago, IL, USA) [30]; the level of significance was P<0.05. The results are expressed as means ± SD.
The sample size calculation for the present study was based on our previous study on elderly men and women [31] and has been calculated for sensitivity of 0.80 and a two-sided significance level of 0.05 indicating 12 subjects sufficient for both study groups.
Results
Subjects' characteristics
Baseline characteristics of the subjects are illustrated in Table 2. Subjects in the SGI-group were smaller at birth compared with the CON-group. Mean BMI of the study groups were similar (26.9 vs. 26.7 kg/m2, P = 0.83). In addition, no significant differences were seen between study groups in fasting TG, FFA, glucose nor insulin concentrations. Cholesterol lowering medication (statins) was used by five subjects in the SGI-group and by four in the CON-group. Seven subjects in the SGI-group and five subjects in the CON-group had impaired glucose tolerance (2-h glucose concentration >7.8 mmol/L). Nine subjects of the SGI-group and ten subjects of the CON-group were breastfed. Duration of breastfeeding did not differ significantly between the groups.
TG and FFA responses
No significant differences were seen in fasting TG concentrations between the two test meals within the groups. TG concentrations are shown in Figure 1, and the postprandial responses expressed as IAUC are shown in Table 3. After the study meal, TG concentrations increased and were at the highest level at 3–4 hours after the study meal (Figure 1). Early growth affected TG responses, and the 4-h TG responses were higher within the SGI-group compared with the CON-group after the FF-meal (P = 0.047) as well as after the REC-meal (P = 0.058) (Table 3). Early growth did not affect postprandial FFA responses (Table 3, Figure 2). Both study meals suppressed FFA initially, and reached the nadir within 60–90 min. Excluding subjects who used statins in the analysis did not have major impact on the results (data not shown).
Mean (± SEM) responses of plasma triglycerides for subjects with slow growth during infancy (open circles, n = 12) and for the control group (filled circles, n = 12) to A) a REC-meal and B) a FF-meal.
Mean (± SEM) responses of plasma free fatty acids for subjects with slow growth during infancy (open circles, n = 12) and for the control group (filled circles, n = 12) to A) a REC-meal and B) a FF-meal.
Glucose and insulin responses
No significant differences were observed in fasting glucose or insulin concentrations between the study groups. The glucose 2-h and 4-h responses did not differ significantly between the study groups (Table 3). Glucose concentrations were peaking 30 min postprandially and approaching baseline values after 60–90 min (Figure 3). The glucose concentration after the REC-meal was significantly higher among the CON-group than among the SGI-group at 15–30 and 180–240 min after the ingestion of the meal.
Mean (± SEM) responses of plasma glucose for subjects with slow growth during infancy (open circles, n = 12) and for the control group (filled circles, n = 12) to A) a REC-meal and B) a FF-meal.
The insulin 2-h and 4-h responses were higher for the SGI-group compared with the CON-group (Table 3, Figure 4), however, this difference was (formally) statistically significant only during the FF-meal (P = 0.036). Excluding subjects who had impaired glucose tolerance in the analysis did not have major impact on the glucose nor insulin results (data not shown). The 4-h IAUCs ratio of insulin to glucose in the REC-meal differed significantly between the study groups (SGI-group ratio 1066±621 vs. CON-group 466±329; P = 0.007). In addition, the ratio of insulin to glucose in the FF-meal were higher in the SGI-group compared with the CON-group (572±369 vs. 318±191; P = 0.053).
Mean (± SEM) responses of plasma insulin for subjects with slow growth during infancy (open circles, n = 12) and for the control group (filled circles, n = 12 except in the FF-meal n = 11) to A) a REC-meal and B) a FF-meal.
Discussion
The objective of this study was to examine the effect of early growth on the postprandial responses of TG, FFA, glucose and insulin in elderly men and women. Our study showed that birth size and growth during infancy have major impact on adult postprandial TG and insulin responses despite similar adult anthropometric characteristics. To our knowledge, this study is the first that have assessed the effect of early growth on postprandial responses in adult life.
In the present study, postprandial TG responses were significantly greater – about 30% higher – for the SGI-group compared with the CON-group. No differences were seen between groups in neither fasting TG concentrations nor fasting FFA nor FFA postprandial responses. Thus, elevated TG responses were not the result of increased adipose tissue lipolysis in the late postprandial state. We suggest that the observed elevated postprandial TG responses might reflect abnormal liver function due to non-optimal liver development during prenatal life and infancy. Liver is a key organ in regulating lipid metabolism, and therefore altered liver growth may permanently alter lipids metabolism. Studies in animal models have demonstrated that undernutrition during gestation affects the liver size at birth [32] and permanently changes lipid metabolism [33] and the microstructure of the liver [34]. Furthermore, it have been shown in epidemiological studies that slow fetal and infant growth [13], [35] or small abdominal circumference at birth, suggesting slow prenatal liver growth, is associated with unfavorable lipid profiles [11].
Two previous studies have found no effect of birth weight on postprandial TG and FFA responses in elderly men and women [15], [16]. Unlike these two studies where the effect of birth weight was investigated, we examined the effect of growth during infancy on postprandial responses. It has previously been observed that fasting TG concentration in adult life is more strongly correlated with slow growth during infancy than with low birth weight [13]. This may partly explain the different findings in the previous studies compared with our findings. However, our study subjects who had grown slowly during the first year of life were also born with a small birth size. Thus, we cannot distinguish between the effect of birth size, infant growth or the combination of the two on TG responses.
Interestingly, whilst glucose responses were slightly, but not statistically significantly, higher in the CON-group in our study, insulin postprandial responses were higher in the SGI-group. A previous study has also shown higher postprandial insulin responses after a standardized breakfast in subjects with low birth weight than in subjects with higher birth weight [17]. Moreover, González-Barranco and co-workers showed that malnutrition during the first year of life had an adverse effect on insulin responses after an OGTT [36]. The higher insulin responses suggest lower insulin sensitivity. In addition to higher insulin responses, insulin resistance may also cause elevated postprandial levels of TGs as observed in our study [37]. Previous studies support this hypothesis of insulin resistance showing that subjects with low birth weight or slow early growth have decreased insulin sensitivity reflecting muscle and adipose tissue insulin resistance [38]–[40]. Both muscle and adipose tissue play a key role in the development of insulin resistance. It is known that those who are thin at birth have reduced lean body mass [41], and have abnormalities in the structure and function of muscle [42], [43]. In addition, undernutrition during gestation may permanently alter the fetal development of adipose tissue and change its metabolic and hormonal functions exposing to the later development of insulin resistance [44], [45]. Excess lipid content in the liver may also cause elevated postprandial lipid responses and insulin resistance [46]. In addition, it has been shown that low birth weight is related to fatty liver disease [47]. Furthermore, as all participants in our study were overweight, the fatty liver, which is closely linked to excess abdominal obesity, may at least partly explain our findings.
It is well known that elevated postprandial lipemia and insulin resistance are closely linked to a number of life style-related diseases, including CVD [18], [19], [48]. A small body size at birth as well as thinness during infancy is also associated with these outcomes [5], [8], [9], [39]. We therefore suggest that our finding of elevated TG and insulin postprandial responses might be one mechanism underlying the increased risk of CVD in people who were small at birth and grew slowly during infancy.
Our study may have some potential limitation. Our study comprised subjects with both normal and impaired glucose tolerance. This might increase the variation of the glucose responses and thus affect the results. We have, however, previously shown that impaired glucose tolerance have effect only on the glucose responses whereas it does not have effect on insulin, TG nor FFA responses [31]. In addition, the limitations of the current work may include a small number of study participants. However, our sample size was based on the power calculations and postprandial studies traditionally include 10 to 30 participants [49]. Our study contained overweight individuals and therefore results may not be directly extrapolated to normal weight individuals. Therefore, our observations need to be confirmed in other studies, which include normal weight subjects as well.
We conclude that small birth size and slow growth during infancy may predict higher postprandial TG and insulin responses in overweight subjects in late adult life. These elevated postprandial responses might be one explanation why people who were small at birth and experiencing slow growth during infancy are at an increased risk of CVD in later life. However, further studies are needed to confirm whether slow growth during infancy without small birth size has effect on postprandial responses.
Acknowledgments
We thank the volunteers for taking the time to participate in postprandial study, Heikki Pakkala and Sigrid Rosten for assisting with the technical aspects of the study, Elina Rintala for assistance in blood sampling.
Author Contributions
Conceived and designed the experiments: M-MP LMV EK JGE. Performed the experiments: M-MP. Analyzed the data: M-MP. Contributed reagents/materials/analysis tools: EK JGE JL. Wrote the paper: M-MP EK JGE. Read and commented on the paper: M-MP LMV EK JGE JL.
References
- 1. Huxley R, Owen CG, Whincup PH, Cook DG, Rich-Edwards J, et al. (2007) Is birth weight a risk factor for ischemic heart disease in later life? Am J Clin Nutr 85: 1244–1250.
- 2. Whincup PH, Kaye SJ, Owen CG, Huxley R, Cook DG, et al. (2008) Birth weight and risk of type 2 diabetes: a systematic review. JAMA 300: 2886–2897.
- 3. Barker DJ (2004) Developmental origins of adult health and disease. J Epidemiol Community Health 58: 114–115.
- 4. Warner MJ, Ozanne SE (2010) Mechanisms involved in the developmental programming of adulthood disease. Biochem J 427: 333–347.
- 5. Barker DJ, Osmond C, Forsén TJ, Kajantie E, Eriksson JG (2005) Trajectories of growth among children who have coronary events as adults. N Engl J Med 353: 1802–1809.
- 6. Eriksson JG, Forsén TJ (2002) Childhood growth and coronary heart disease in later life. Ann Med 34: 157–161.
- 7. Eriksson JG, Forsén TJ, Osmond C, Barker DJ (2003) Pathways of infant and childhood growth that lead to type 2 diabetes. Diabetes Care 26: 3006–3010.
- 8. Eriksson JG, Osmond C, Kajantie E, Forsén TJ, Barker DJ (2006) Patterns of growth among children who later develop type 2 diabetes or its risk factors. Diabetologia 49: 2853–2858.
- 9. Osmond C, Kajantie E, Forsén TJ, Eriksson JG, Barker DJ (2007) Infant growth and stroke in adult life: the Helsinki birth cohort study. Stroke 38: 264–270.
- 10. Phillips D, Goulden P, Syddall H, Aihie Sayer A, Dennison E, et al. (2005) Fetal and infant growth and glucose tolerance in the Hertfordshire Cohort Study: a study of men and women born between 1931 and 1939. Diabetes 54: S145–150.
- 11. Barker DJ, Martyn CN, Osmond C, Hales CN, Fall CH (1993) Growth in utero and serum cholesterol concentrations in adult life. BMJ 307: 1524–1527.
- 12. Huxley R, Owen CG, Whincup PH, Cook DG, Colman S, et al. (2004) Birth weight and subsequent cholesterol levels: exploration of the “fetal origins” hypothesis. JAMA 292: 2755–2764.
- 13. Kajantie E, Barker DJ, Osmond C, Forsén T, Eriksson JG (2008) Growth before 2 years of age and serum lipids 60 years later: the Helsinki Birth Cohort study. Int J Epidemiol 37: 280–289.
- 14. Mi J, Law C, Zhang KL, Osmond C, Stein C, et al. (2000) Effects of infant birthweight and maternal body mass index in pregnancy on components of the insulin resistance syndrome in China. Ann Intern Med 132: 253–260.
- 15. Byrne CD, Wareham NJ, Phillips DI, Hales CN, Martensz ND (1997) Is an exaggerated postprandial triglyceride response associated with the component features of the insulin resistance syndrome? Diabet Med 14: 942–950.
- 16. Kensara OA, Wooton SA, Phillips DI, Patel M, Hoffman DJ, et al. (2006) Substrate-energy metabolism and metabolic risk factors for cardiovascular disease in relation to fetal growth and adult body composition. Am J Physiol Endocrinol Metab 291: E365–371.
- 17. Schou JH, Pilgaard K, Vilsbøll T, Jensen CB, Deacon CF, et al. (2005) Normal secretion and action of the gut incretin hormones glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in young men with low birth weight. J Clin Endocrinol Metab 90: 4912–4919.
- 18. Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, et al. (2007) Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 298: 309–316.
- 19. Nordestegaard BG, Benn M, Sehnohr P, Tybjærg-Hansen A (2007) Nonfasting triglycerides and risk of myocardial infraction, ischemic heart disease, and death in men and women. JAMA 298: 299–308.
- 20. Rendell MS, Jovanovic L (2006) Targeting postprandial hyperglycemia. Metabolism 55: 1263–1281.
- 21. Kolovou GD, Mikhailidis DP, Kovar J, Lairon D, Nordestgaard BG, et al. (2011) Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement. Curr Vasc Pharmacol 9: 258–270.
- 22. O'Keefe JH, Bell DS (2007) Postprandial hyperglycemia/hyperlipidemia (postprandial dysmetabolism) is a cardiovascular risk factor. Am J Cardiol 100: 899–904.
- 23.
World Health Organization (2004) Human energy requirements. Report of a Joint FAO/WHO/UNU Expert Consultation. Rome, 17–24 October 2001.
- 24.
Nordic Council of Ministers (2004) Nordic Nutrition Recommendations 2004: Integrating nutrition and physical activity. Copenhagen: Nordic Council of Ministers.
- 25. Banauch D, Brummer W, Ebeling W, Metz H, Rindfrey H, et al. (1975) [A glucose dehydrogenase for the determination of glucose concentrations in body fluids (author's transl)]. Z Klin Chem Klin Biochem 13: 101–107.
- 26. Fossati P, Prencipe L (1982) Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 28: 2077–2080.
- 27. Mulder C, Schouten JA, Popp-Snijders C (1983) Determination of free fatty acids: a comparative study of the enzymatic versus the gas chromatographic and the colorimetric method. J Clin Chem Clin Biochem 21: 823–827.
- 28. Moriyama M, Hayashi N, Ohyabu C, Mukai M, Kawano S, et al. (2006) Performance evaluation and cross-reactivity from insulin analogs with the ARCHITECT insulin assay. Clin Chem 52: 1423–1426.
- 29.
World Health Organization (1998) Carbohydrates in human nutrition. Report of a joint FAO/WHO Expert Consultation. Rome, 14–18 April, 1997.
- 30.
SPSS Inc. (2009) PASW Statistics Rel. 18.0.0. Chicago: SPSS Inc.
- 31. Perälä M-M, Hätönen KA, Virtamo J, Eriksson JG, Sinkko HK, et al. (2011) Impact of overweight and glucose tolerance on postprandial responses to high- and low-glycaemic index meals. Br J Nutr 105: 1627–1634.
- 32. Winick M, Noble A (1966) Cellular response in rats during malnutrition at various ages. J Nutr 89: 300–306.
- 33. Lane RH, Kelley DE, Gruetzmacher EM, Devaskar SU (2001) Uteroplacental insufficiency alters hepatic fatty acid-metabolizing enzymes in juvenile and adult rats. Am J Physiol Regul Integr Comp Physiol 280: R183–190.
- 34. Burns SP, Desai M, Cohen RD, Hales CN, Iles RA, et al. (1997) Gluconeogenesis, glucose handling, and structural changes in livers of the adult offspring of rats partially deprived of protein during pregnancy and lactation. J Clin Invest 100: 1768–1774.
- 35. Roseboom T, de Rooij S, Painter R (2006) The Dutch famine and its long-term consequences for adult health. Early Hum Dev 82: 485–491.
- 36. González-Barranco J, Rios-Torres JM, Castillo-Martínez L, López-Alvarenga JC, Aguilar-Salinas CA, et al. (2003) Effect of malnutrition during the first year of life on adult plasma insulin and glucose tolerance. Metabolism 52: 1005–1011.
- 37. Kim HS, Abbasi F, Lamendola C, McLaughlin T, Reaven GM (2001) Effect of insulin resistance on postprandial elevations of remnant lipoprotein concentrations in postmenopausal women. Am J Clin Nutr 74: 592–595.
- 38. Eriksson JG, Forsén T, Tuomilehto J, Jaddoe VW, Osmond C, et al. (2002) Effects of size at birth and childhood growth on the insulin resistance syndrome in elderly individuals. Diabetologia 45: 342–348.
- 39. Hales CN, Barker DJ, Clark PM, Cox LJ, Fall C, et al. (1991) Fetal and infant growth and impaired glucose tolerance at age 64. BMJ 303: 1019–1022.
- 40. Phillips DI, Barker DJ, Hales CN, Hirst S, Osmond C (1994) Thinness at birth and insulin resistance in adult life. Diabetologia 37: 150–154.
- 41. Eriksson J, Forsén T, Tuomilehto J, Osmond C, Barker D (2002) Size at birth, fat-free mass and resting metabolic rate in adult life. Horm Metab Res 34: 72–76.
- 42. Jensen CB, Martin-Gronert MS, Storgaard H, Madsbad S, Vaag A, et al. (2008) Altered PI3-kinase/Akt signalling in skeletal muscle of young men with low birth weight. PLoS One 3: e3738.
- 43. Taylor DJ, Thompson CH, Kemp GJ, Barnes PR, Sanderson AL, et al. (1995) A relationship between impaired fetal growth and reduced muscle glycolysis revealed by 31P magnetic resonance spectroscopy. Diabetologia 38: 1205–1212.
- 44. Boiko J, Jaquet D, Chevenne D, Rigal O, Czernichow P, et al. (2005) In situ lipolytic regulation in subjects born small for gestational age. Int J Obes (Lond) 29: 565–570.
- 45. Maiorana A, Del Bianco C, Cianfarani S (2007) Adipose tissue: A metabolic regulator. Potential implications for the metabolic outcome of subjects born small for gestational age (SGA). Rev Diabet Stud 4: 134–146.
- 46. Kotronen A, Yki-Järvinen H (2008) Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol 28: 27–38.
- 47. Fraser A, Ebrahim S, Smith GD, Lawlor DA (2008) The associations between birthweight and adult markers of liver damage and function. Paediatr Perinat Epidemiol 22: 12–21.
- 48. Bansilal S, Farkouh ME, Fuster V (2007) Role of insulin resistance and hyperglycemia in the development of atherosclerosis. Am J Cardiol 99(suppl): 6B–14B.
- 49. Lairon D, Lopez-Miranda J, Williams C (2007) Methodology for studying postprandial lipid metabolism. Eur J Clin Nutr 61: 1145–1161.